Related Experiment Video
Updated: Apr 23, 2026

Electrocardiogram Recordings in Anesthetized Mice using Lead II
Published on: June 20, 2020
Het effect van galantamine op de ecg- geleidingstijden
I C Jobse1, R A M de Jonckheere
1arts in op leiding tot klinisch geriater, afdeling klinische geriatrie, Amphia Ziekenhuis, Breda, The Netherlands, dulve@hotmail.com.
The Effect Of Galantamine On Cardiac Conduction Time Background:
Galantamine, one of the acethylcholinesterase inhibitors (AChEI), is used in the treatment of Alzheimer's disease. However AChEI have been associated with adverse events, including cardiac events. The objective of this prospective, observational study is to evaluate the association between galantamine and incident cardiac conduction abnormalities.
Methods:
A total of 64 patients, who visited an out - patient clinic of a geriatric department were enrolled in the study. All patients were diagnosed with Alzheimer's disease and started with a capsule containing 8 mg of galantamine. Subsequently, if galantamine was well tolerated, the dosage was raised every 4 weeks, to an eventual dosage of 24 mg/ day. The mean follow - up period was 4 months. ECG parameters were evaluated at baseline and after start of galantamine at each galantamine dose level (8, 16, 24 mg / day).
Results:
No significant differences in electrocardiographic measurements before and during treatment with galantamine were found.
Conclusion:
No significant changes in ECG parameters relative to baseline were found with galantamine treatment. Also after adjustment for concomitant cardioactive medications and cardiovascular comorbidity, no significant changes were found.
More Related Videos
08:28Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus
Published on: April 5, 2011
10:17Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System
Published on: April 11, 2025
Related Concept Videos
Electrocardiogram
Three major waveforms are present in a typical ECG recording: the P wave, the QRS complex, and...
Cardiac Action Potential
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
Correlation between ECG and Cardiac Cycle
A cardiac action potential originates in the SA node and spreads throughout the atria and the AV node in approximately 0.03 seconds. This results in the P wave in an ECG and triggers atrial contraction. The action potential is then briefly slowed at the AV node, allowing the atria to contract and fill the ventricles with blood before...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers